These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11730333)

  • 1. Characterization of noncovalent complexes of recombinant human monoclonal antibody and antigen using cation exchange, size exclusion chromatography, and BIAcore.
    Santora LC; Kaymakcalan Z; Sakorafas P; Krull IS; Grant K
    Anal Biochem; 2001 Dec; 299(2):119-29. PubMed ID: 11730333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of recombinant human monoclonal tissue necrosis factor-alpha antibody using cation-exchange HPLC and capillary isoelectric focusing.
    Santora LC; Krull IS; Grant K
    Anal Biochem; 1999 Nov; 275(1):98-108. PubMed ID: 10542114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analyses of complex formation and binding sites between human tumor necrosis factor-alpha and its three antagonists elucidate their different neutralizing mechanisms.
    Kim MS; Lee SH; Song MY; Yoo TH; Lee BK; Kim YS
    J Mol Biol; 2007 Dec; 374(5):1374-88. PubMed ID: 17996896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions.
    Wen J; Arakawa T; Philo JS
    Anal Biochem; 1996 Sep; 240(2):155-66. PubMed ID: 8811899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of uncertainty in size-exclusion chromatography with a double detection system (light-scattering and refractive index).
    Oliva A; Llabrés M; Fariña JB
    Talanta; 2009 May; 78(3):781-9. PubMed ID: 19269428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel TNFalpha antagonizing peptide-Fc fusion protein designed based on CDRs of TNFalpha neutralizing monoclonal antibody.
    Qin W; Feng J; Zhang W; Li Y; Shen B
    Biochem Biophys Res Commun; 2004 Sep; 322(3):1024-8. PubMed ID: 15336567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.
    Lau H; Pace D; Yan B; McGrath T; Smallwood S; Patel K; Park J; Park SS; Latypov RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):868-76. PubMed ID: 20206584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
    Feng J; Li Y; Zhang W; Shen B
    Immunol Lett; 2005 May; 98(2):311-6. PubMed ID: 15860233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody binding affinity determined by microchip-based capillary electrophoresis.
    Chiem NH; Harrison DJ
    Electrophoresis; 1998 Nov; 19(16-17):3040-4. PubMed ID: 9870410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational methods for predicting human monoclonal antibodies retention in protein A affinity chromatography and cation exchange chromatography. Structure-based chromatography design for monoclonal antibodies.
    Ishihara T; Kadoya T; Yoshida H; Tamada T; Yamamoto S
    J Chromatogr A; 2005 Nov; 1093(1-2):126-38. PubMed ID: 16233878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the glycosylation state of a recombinant monoclonal antibody using weak cation exchange chromatography and mass spectrometry.
    Gaza-Bulseco G; Bulseco A; Chumsae C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):155-60. PubMed ID: 18164669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of immunochemical reaction for human growth hormone with its monoclonal antibody by perfusion protein G affinity chromatography and capillary zone electrophoresis.
    Zou H; Zhang Y; Lu P; Krull IS
    Biomed Chromatogr; 1996; 10(2):78-82. PubMed ID: 8924731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complex formation analysed by high-performance size exclusion chromatography (HPLC-SEC) using either 125I-labelled antigen or enzyme-linked immunosorbent assay (ELISA) for detection.
    Holmskov-Nielsen U; Jensenius JC; Erb K; Husby S
    Immunology; 1984 Apr; 51(4):809-14. PubMed ID: 6423527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homopolyvalent antibody-antigen interaction kinetic studies with use of a dual-polarization interferometric biosensor.
    Lin S; Lee CK; Lin YH; Lee SY; Sheu BC; Tsai JC; Hsu SM
    Biosens Bioelectron; 2006 Dec; 22(5):715-21. PubMed ID: 16569500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS.
    Atmanene C; Wagner-Rousset E; Malissard M; Chol B; Robert A; Corvaïa N; Van Dorsselaer A; Beck A; Sanglier-Cianférani S
    Anal Chem; 2009 Aug; 81(15):6364-73. PubMed ID: 19588976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of protein aggregation, degradation, and absolute molecular weight by size exclusion chromatography-multiangle laser light scattering.
    Ye H
    Anal Biochem; 2006 Sep; 356(1):76-85. PubMed ID: 16839514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8.
    Rathanaswami P; Roalstad S; Roskos L; Su QJ; Lackie S; Babcook J
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1004-13. PubMed ID: 16038881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microheterogeneous monoclonal antibody subspecies with differential hepatitis C virus core antigen binding properties identified by SEC-HPLC.
    Muerhoff AS; Rupprecht K; Ruan Q; Zeck B; Ramsay C; Zhao C; Desai SM
    J Immunol Methods; 2009 Jun; 345(1-2):60-9. PubMed ID: 19375428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial coupling of ion-exchange and size-exclusion chromatography to determine aggregation levels in mAbs in the presence of a proteinaceous excipient, recombinant human serum albumin.
    Weisbjerg PL; Caspersen MB; Cook K; Van De Weert M
    J Pharm Sci; 2015 Feb; 104(2):548-56. PubMed ID: 25447946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of antigen-antibody complexes by size-exclusion chromatography coupled with low-angle light-scattering photometry and viscometry.
    Qian RL; Mhatre R; Krull IS
    J Chromatogr A; 1997 Nov; 787(1-2):101-9. PubMed ID: 9408997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.